EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Rationale and Design of the Türkiye Heart Failure (TURK‐HF) Registry

Umut Kocabas iD, Selda Murat iD, Tarık Kıvrak, Bektaş Murat iD, Cihan Altın, Cennet Yıldız iD, Şeyda Günay Polatkan, Selma Akdeniz Oskay, Zeynep Ulutaş iD, Duygu İnan iD, Nuran Günay, Dilay Karabulut und 6 weitere

Clinical Cardiology · 2026-05 · 49 (5)

DOI: 10.1002/clc.70353 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Cardiology, online erschienen am 21.05.2026. Verfasst von Umut Kocabas und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Başkent University Izmir Hospital, Izmir, Türkiye. Hauptthemen laut MEDLINE: Registries, Heart Failure, Quality of Life, Stroke Volume. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The Türkiye Heart Failure (TURK‐HF) registry aims to identify the sociodemographic and clinical characteristics, management strategies, and outcomes of patients with heart failure (HF) and to assess the implementation of evidence‐based HF therapies in Türkiye.

Methods

The TURK‐HF registry is a national, multicenter, prospective, observational study of unselected patients with HF regardless of ejection fraction. A total of 46 investigators from 38 centers in 22 cities across Türkiye participated in the registry. The study investigators will gain access to the electronic case report form via www.turkhf.com website using their usernames and passwords. The baseline assessment of the patients will include sociodemographic data, primary care access information, frailty assessment, health‐related quality of life questionnaire, HF‐related information, medical history and comorbidities, physical examination findings, electrocardiographic and echocardiographic data, H 2 FPEF score calculation, laboratory results, and medical and device‐based HF therapies. The management strategies and potential complications of patients hospitalized with acute HF will be systematically documented. Follow‐up data will be collected at regular outpatient visits every 6 months with a margin of error of 1 month. The clinical endpoints of the TURK‐HF registry were cardiovascular or all‐cause mortality, HF‐related hospitalizations, clinician‐interpreted outcomes, patient‐reported outcomes, and surrogate endpoints, either alone or in combination. The TURK‐HF registry was registered at ClinicalTrials.gov (ID: NCT06707220).

Conclusion

The TURK‐HF registry offers comprehensive and distinctive insights into contemporary HF clinical characteristics, diagnostic methods, treatments, and outcomes. This registry has the potential to influence implementation strategies, clinical research, and public policies across Türkiye.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RegistriesHeart FailureQuality of LifeStroke VolumeHumansProspective StudiesFemaleMale

Stichwörter der Autor:innen

Türkiyeheart failureoutcomereal‐world dataregistrytreatment

Autor:innen und Institutionen

  • Department of Cardiology, Başkent University Izmir Hospital, Izmir, Türkiye.
  • Department of Cardiology, Eskisehir Osmangazi University, Eskisehir, Türkiye.
  • Department of Cardiology, Firat University Medical School, Elazig, Türkiye.
  • Department of Cardiology, Eskisehir City Hospital, Eskisehir, Türkiye.
  • Department of Cardiology, Faculty of Medicine, Medical Point Hospital, Izmir University of Economics, Izmir, Türkiye.
  • Department of Cardiology, Bakirkoy Dr Sadi Konuk Training and Research Hospital, Istanbul, Türkiye.

ORCID-Profile: Umut Kocabas, Selda Murat, Bektaş Murat, Cennet Yıldız, Zeynep Ulutaş, Duygu İnan, Fahri Çakan

Zitieren

APA

Kocabas, U., Murat, S., Kıvrak, T., Murat, B., Altın, C., Yıldız, C., Polatkan, Ş. G., Oskay, S. A., Ulutaş, Z., İnan, D., Günay, N., Karabulut, D., Çakan, F., Yavuz, V., Ergin, I., Türk, U. Ö., Tengiz, İ., & TURK‐HF Registry Investigators (2026). Rationale and Design of the Türkiye Heart Failure (TURK‐HF) Registry. Clinical Cardiology, 49(5). https://doi.org/10.1002/clc.70353

Vancouver

Kocabas U, Murat S, Kıvrak T, Murat B, Altın C, Yıldız C, et al. Rationale and Design of the Türkiye Heart Failure (TURK‐HF) Registry. Clinical Cardiology. 2026;49(5). doi:10.1002/clc.70353

BibTeX
@article{Kocabas2026,
  author = {Kocabas, Umut and Murat, Selda and Kıvrak, Tarık and Murat, Bektaş and Altın, Cihan and Yıldız, Cennet and Polatkan, Şeyda Günay and Oskay, Selma Akdeniz and Ulutaş, Zeynep and İnan, Duygu and Günay, Nuran and Karabulut, Dilay and Çakan, Fahri and Yavuz, Veysel and Ergin, Isil and Türk, Uğur Önsel and Tengiz, İstemihan and TURK‐HF Registry Investigators, TURK‐HF Registry Investigators},
  title = {Rationale and Design of the Türkiye Heart Failure (TURK‐HF) Registry},
  journal = {Clinical Cardiology},
  year = {2026},
  volume = {49},
  number = {5},
  doi = {10.1002/clc.70353}
}
Kostenlos starten →